Latest Breaking News On - Novel dry powder formulation - Page 1 : comparemela.com

/PRNewswire/ Pulmatrix, Inc. (NASDAQ: PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary.

United statesTimothy mccarthyMargaret wasilewskiPulmatrix incAmerican headache societyAmerican headache society annual scientific meetingPrnewswire pulmatrix incCompany quarterly reports on formExchange commissionDrug administrationAnnual meetingAssess safetyNovel dry powder formulationOral inhalationCentral timeChief medical officer